-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
With the increasingly difficult development of small molecule drugs, antibody drugs, cell and gene therapy have attracted the attention of major pharmaceutical companies around the world
Since the launch of the first cell therapy Kymriah in 2017, five CAR-T therapies for hematological tumors have been approved for marketing in the United States
The future has come, BIFT China 2022-the 5th China Biopharmaceutical Innovation and Frontier Technology Summit co-hosted by GEC Events, SAPA-GP American Chinese Medicine Development Association Greater Philadelphia Branch, and CBA American Chinese Biomedical Technology Association It will be held in Shanghai, China on July 5-6, 2022
BIFT China 2022 will show you the latest research and development trends and innovative breakthroughs in biological products such as antibody-drug conjugates (ADC), double antibody, CAR-T, gene therapy, and nanobodies
For more detailed information, please log on to the websiteor contact the conference group at 021-3112-3968, or send an email to enquiry@gecgroup.
Conference Features
● 800+ professional high-level participants
Some of the main topics
Innovative antibody/protein drug R&D, process and production
Development and industrialization of gene and cell therapy drugs
Wonderful review of the past
Please look forward to more exciting BIFT China 2022 summit!
Tel: 021-3112 3968